Chun-Nan Chen, Ph.D.


Chun-Nan Chen founded SCT in 2008 with partners Jim Bowlby and Rich Jorgensen. Dr. Chen directed human genome mapping at Applied Biosystems. Dr. Chen was a visiting scholar at Yang Ming University, a member of Taiwan’s National Science Council on Biotechnology, and an adviser for the Executive Yuan. He was also an invited speaker at numerous scientific meetings both in Taiwan and the United States, and taught the Advanced Genome Sequence Analysis course at Cold Spring Harbor Laboratory.

Dr. Chen received his B.S. from National Taiwan University, his Ph.D. from Michigan State University, and his postdoctoral training in Biochemistry Molecular Biology from UC San Francisco, and has held senior scientific positions at Celera Genomics, Applied Biosystems, Pharmagenesis, SyStemix and DesignRx Pharmaceuticals. Dr. Chen is a registered United States Patent Agent.

Allison Schulkins


Allison Schulkins has experience in molecular biology, experimental design, fluid dynamics, and project management. She has spent years leading efforts to improve and validate SCT’s processes for cell isolation, antibody screening, and amplification techniques for Next Generation Sequencing. She has used her expertise across SCT’s converging fields to manage laboratory operations and client projects.

Ms. Schulkins has a B.S. in Biochemistry from the University of California, Santa Barbara and a M.S. in Chemical Engineering from San Jose State University. She has laboratory experience in cloning, enzymatic processes, biopolymers, and chemical finishing.

Leyan (Joy) Tang


Joy Tang leads bioinformatic efforts by developing and applying sophisticated algorithms and simulations for image processing, Next Generation Sequencing output, and other experimental readouts to advance SCT’s technology. Ms. Tang has been instrumental in implementing new laboratory procedures, dissecting diverse data, spotting subtle trends, and providing critical solutions for overcoming technical challenges.

Ms. Tang has a B.S. in Computer Engineering from the University of Electronic Science and Technology of China and a M.S. in Computer Science from San Jose State University. She has experience in computer science, bioinformatics, molecular biology, MEMS, and mechanical engineering.

Dexter Girton, Ph.D.

Vice President, Engineering

Dr. Girton has over thirty years experience in design, fabrication and testing of electro-optic materials and MEMS devices. In addition, Dr. Girton is an expert at wafer processing and fabrication techniques and is SCT’s main interface to the Stanford Nanofabrication Facility.

Dr. Girton obtained his B.S., M.S., & Ph.D. in Electrical Engineering (Solid State Physics) from Ohio State University.

Rich Jorgensen, MBA

Vice President, Marketing

Rich Jorgensen is SCT’s corporate marketing, public and investor relations, and business development executive. He has experience in both biotechnology and computer technology industries. Mr. Jorgensen is the founder and leader of the company patent committee and contributed to filings related to data encoding and encryption. Mr. Jorgensen is a past advising member to the Computer History Museum in Mountain View, CA and a member of SAG-AFTRA.

Mr. Jorgensen has his B.S. in Mechanical Engineering from the University of California, Berkeley, his MBA from Santa Clara University, and additional Executive Education from the Wharton School of Business at the University of Pennsylvania.

James (Jim) Bowlby

Co-Founder, Corporate Secretary

Jim Bowlby is an experienced mathematician and physicist, who ran the Bioinformatics and Algorithm group at Applied Biosystems. The group improved the DNA base calling using a wide variety of advanced mathematics. At Woodside Technology, he developed an array-based DNA amplification system. At Vita Genomics, he experimented with advanced haplotyping techniques to mine the Celera database for disease genes prevalent in Asian populations.

Mr. Bowlby has a B.A. in mathematics and a M.A. in physics from the University of California, Berkeley, and studied under Nobel Laureates Owen Chamberlain and E. O. Lawrence and Panofsky Prize winner David Nygren at Lawrence Berkeley Labs. Mr. Bowlby was previously CTO of Anagene Corporation.


Mark J. Shlomchik, M.D., Ph.D.

Chair of Department of Immunology, University of Pittsburgh School of Medicine

George Church, Ph.D.

Professor of Genetics, Harvard Medical School and Director of the Center for Computational Genetics

Yen-Ming Hsu, Ph.D.

CEO, AB Biosciences, Inc.
Boston, Massachusetts.